These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 7668529)
1. The soluble interleukin-6 receptor. Rose-John S; Ehlers M; Grötzinger J; Müllberg J Ann N Y Acad Sci; 1995 Jul; 762():207-20; discussion 220-1. PubMed ID: 7668529 [No Abstract] [Full Text] [Related]
2. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. Bellido T; Stahl N; Farruggella TJ; Borba V; Yancopoulos GD; Manolagas SC J Clin Invest; 1996 Jan; 97(2):431-7. PubMed ID: 8567964 [TBL] [Abstract][Full Text] [Related]
3. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor. Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716 [TBL] [Abstract][Full Text] [Related]
4. Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism. Hui W; Bell M; Carroll G Cytokine; 2000 Feb; 12(2):151-5. PubMed ID: 10671300 [TBL] [Abstract][Full Text] [Related]
5. LIF receptor-gp130 interaction investigated by homology modeling: implications for LIF binding. Smith DK; Treutlein HR Protein Sci; 1998 Apr; 7(4):886-96. PubMed ID: 9568895 [TBL] [Abstract][Full Text] [Related]
6. A ciliary neurotrophic factor-sensitive human myeloma cell line. Gu ZJ; Zhang XG; Hallet MM; Lu ZY; Wijdenes J; Rossi JF; Klein B Exp Hematol; 1996 Aug; 24(10):1195-200. PubMed ID: 8765494 [TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA. Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477 [TBL] [Abstract][Full Text] [Related]
8. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130. Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060 [TBL] [Abstract][Full Text] [Related]
9. Identification of a Leu-lle internalization motif within the cytoplasmic domain of the leukaemia inhibitory factor receptor. Thiel S; Behrmann I; Timmermann A; Dahmen H; Müller-Newen G; Schaper F; Tavernier J; Pitard V; Heinrich PC; Graeve L Biochem J; 1999 Apr; 339 ( Pt 1)(Pt 1):15-9. PubMed ID: 10085222 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 family of cytokines induced activation of different functional sites expressed by gp130 transducing protein. Chevalier S; Fourcin M; Robledo O; Wijdenes J; Pouplard-Barthelaix A; Gascan H J Biol Chem; 1996 Jun; 271(25):14764-72. PubMed ID: 8662918 [TBL] [Abstract][Full Text] [Related]
11. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain. Watanabe D; Yoshimura R; Khalil M; Yoshida K; Kishimoto T; Taga T; Kiyama H Eur J Neurosci; 1996 Aug; 8(8):1630-40. PubMed ID: 8921254 [TBL] [Abstract][Full Text] [Related]
12. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Stahl N; Boulton TG; Farruggella T; Ip NY; Davis S; Witthuhn BA; Quelle FW; Silvennoinen O; Barbieri G; Pellegrini S Science; 1994 Jan; 263(5143):92-5. PubMed ID: 8272873 [TBL] [Abstract][Full Text] [Related]
13. Designer cytokines: targeting actions to cells of choice. Economides AN; Ravetch JV; Yancopoulos GD; Stahl N Science; 1995 Nov; 270(5240):1351-3. PubMed ID: 7481821 [TBL] [Abstract][Full Text] [Related]
14. Agonistic and antagonistic variants of ciliary neurotrophic factor (CNTF) reveal functional differences between membrane-bound and soluble CNTF alpha-receptor. Di Marco A; Gloaguen I; Demartis A; Saggio I; Graziani R; Paonessa G; Laufer R J Biol Chem; 1997 Sep; 272(37):23069-75. PubMed ID: 9287306 [TBL] [Abstract][Full Text] [Related]
15. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response. Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548 [TBL] [Abstract][Full Text] [Related]
16. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex. Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136 [TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of a specific receptor for mouse oncostatin M. Lindberg RA; Juan TS; Welcher AA; Sun Y; Cupples R; Guthrie B; Fletcher FA Mol Cell Biol; 1998 Jun; 18(6):3357-67. PubMed ID: 9584176 [TBL] [Abstract][Full Text] [Related]
19. The N-terminal cytokine binding domain of LIFR is required for CNTF binding and signaling. He W; Gong K; Smith DK; Ip NY FEBS Lett; 2005 Aug; 579(20):4317-23. PubMed ID: 16051226 [TBL] [Abstract][Full Text] [Related]
20. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors. Malaval L; Liu F; Vernallis AB; Aubin JE J Cell Physiol; 2005 Aug; 204(2):585-93. PubMed ID: 15751050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]